Literature DB >> 21369802

Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues.

Eun Shin1, Kyoung-Bun Lee, Soo-Young Park, Soo-Hee Kim, Han-Suk Ryu, Young-Nyun Park, Eunsil Yu, Ja-June Jang.   

Abstract

We elucidated the genetic profile of hepatoblastomas (HBLs) to identify diagnostic and prognostic markers. RNA was extracted from 32 formalin-fixed, paraffin-embedded HBLs and corresponding nonneoplastic liver (NNL) tissues, and cDNA-mediated annealing, selection, extension, and ligation (DASL) chip assays were performed. Immunohistochemistry was performed to confirm the expression of Yin Yang 1 (YY1) protein in HBL. Twenty-four genes that were associated with signal transduction, cell-cell adhesion, cell cycle regulation, and apoptosis were differentially expressed in HBL and NNL tissues. Two apoptosis-associated genes, MYCN and BIRC5, were highly upregulated in HBL. Eight genes, including YY1 and IGF1, were upregulated in HBL cases that had a poor prognosis. Thirty-eight genes, including YY1, were differentially expressed according to histologic differentiation of HBL, and the immunohistochemical expression of YY1 was correlated with poor HBL differentiation. Thus, using DASL chip assays, we report the gene expression profiles of HBL, which suggest new candidate prognostic and diagnostic genetic markers and putative therapeutic targets for HBL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21369802     DOI: 10.1007/s00428-011-1043-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  31 in total

1.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.

Authors:  R G Weber; T Pietsch; D von Schweinitz; P Lichter
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Highly parallel SNP genotyping.

Authors:  J B Fan; A Oliphant; R Shen; B G Kermani; F Garcia; K L Gunderson; M Hansen; F Steemers; S L Butler; P Deloukas; L Galver; S Hunt; C McBride; M Bibikova; T Rubano; J Chen; E Wickham; D Doucet; W Chang; D Campbell; B Zhang; S Kruglyak; D Bentley; J Haas; P Rigault; L Zhou; J Stuelpnagel; M S Chee
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2003

Review 3.  Hepatoblastoma: an oncological review.

Authors:  Derek J Roebuck; Giorgio Perilongo
Journal:  Pediatr Radiol       Date:  2006-01-11

4.  Oncogene amplification and expression in pediatric solid tumors.

Authors:  J Mares; V Polanská; H Görgens; Z Sedlácek; T Maríková; P Bocek; R Kodet; J Schackert; P Goetz
Journal:  Neoplasma       Date:  1998       Impact factor: 2.575

5.  Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma.

Authors:  S N Akmal; K Yun; J MacLay; Y Higami; T Ikeda
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

Review 6.  Where do we stand with hepatoblastoma? A review.

Authors:  J Marco Schnater; S Eleonore Köhler; Wouter H Lamers; Dietrich von Schweinitz; Daniël C Aronson
Journal:  Cancer       Date:  2003-08-15       Impact factor: 6.860

7.  Transcriptional profiling in hepatoblastomas using high-density oligonucleotide DNA array.

Authors:  Toshihito Nagata; Yasuo Takahashi; Yukimoto Ishii; Satoshi Asai; Yayoi Nishida; Akiko Murata; Tsugumichi Koshinaga; Masahiro Fukuzawa; Minoru Hamazaki; Keiko Asami; Etsuro Ito; Hitoshi Ikeda; Hideo Takamatsu; Kenichi Koike; Atsushi Kikuta; Minoru Kuroiwa; Arata Watanabe; Yoshiyuki Kosaka; Hiroo Fujita; Munenori Miyake; Hideo Mugishima
Journal:  Cancer Genet Cytogenet       Date:  2003-09

8.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

Review 9.  MYCN in neuronal tumours.

Authors:  Manfred Schwab
Journal:  Cancer Lett       Date:  2004-02-20       Impact factor: 8.679

10.  Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutation.

Authors:  Rie Yoshida; Tsutomu Ogata; Nobuhide Masawa; Toshiro Nagai
Journal:  Pediatr Blood Cancer       Date:  2008-06       Impact factor: 3.167

View more
  8 in total

Review 1.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

2.  Regulatory network analysis of genes and microRNAs in human hepatoblastoma.

Authors:  Jimin He; Xiaoxin Guo; Linlin Sun; Ning Wang; Jiwei Bao
Journal:  Oncol Lett       Date:  2016-09-27       Impact factor: 2.967

3.  Expression of YY1 in Differentiated Thyroid Cancer.

Authors:  Jéssica Arribas; Josep Castellví; Ricard Marcos; Carles Zafón; Antonia Velázquez
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

4.  Identification of potential key genes and miRNAs involved in Hepatoblastoma pathogenesis and prognosis.

Authors:  Taha Aghajanzadeh; Kiarash Tebbi; Mahmood Talkhabi
Journal:  J Cell Commun Signal       Date:  2020-10-13       Impact factor: 5.782

5.  YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.

Authors:  Si-Yao Qu; Yuan-Yuan Sun; Yun-Hui Li; Zhen-Ming Xu; Wei-Neng Fu
Journal:  Cancer Med       Date:  2017-05-09       Impact factor: 4.452

6.  Integrated Protein-Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma.

Authors:  Linlin Tian; Tong Chen; Jiaju Lu; Jianguo Yan; Yuting Zhang; Peifang Qin; Sentai Ding; Yali Zhou
Journal:  Front Cell Dev Biol       Date:  2021-02-26

7.  Genotypic Characteristics of Hepatoblastoma as Detected by Next Generation Sequencing and Their Correlation With Clinical Efficacy.

Authors:  Huimin Hu; Weiling Zhang; Tian Zhi; Jing Li; Yuan Wen; Fan Li; Yanyan Mei; Dongsheng Huang
Journal:  Front Oncol       Date:  2021-08-06       Impact factor: 6.244

8.  Up-Regulated Proteins Have More Protein-Protein Interactions than Down-Regulated Proteins.

Authors:  Lopamudra Dey; Sanjay Chakraborty; Saroj Kumar Pandey
Journal:  Protein J       Date:  2022-10-11       Impact factor: 4.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.